Quest Diagnostics Incorporated (DGX) Stock Analysis & Winston Score

Quest Diagnostics is one of the largest medical testing companies in the United States. It collects blood, urine, and tissue samples from patients and runs laboratory tests that help doctors diagnose diseases, monitor health conditions, and guide treatment decisions. The company serves patients, hospitals, physician offices, and health insurers across a wide range of tests — from routine cholesterol checks to complex genetic screenings. Quest makes money by charging for each test it performs, billing either the patient's insurance company, government programs like Medicare and Medicaid, or the patient directly. It operates thousands of patient service centers and processes millions of tests each year, giving it a large scale advantage that is difficult for smaller labs to match. The main growth driver is expanding its test menu into higher-value areas like genetic and molecular diagnostics, while the main risk is ongoing pricing pressure from insurers and government payers, which can squeeze revenue per test over time.